Effects of adrenergic neurone blocking agents on voluntary muscle stimulated at different frequencies.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D000963:Antimetabolites / Q000494:pharmacology; D001949:Bretylium Compounds / Q000494:pharmacology; D002415:Cats; D003964:Diaphragm / Q000187:drug effects / Q000502:physiology; D004558:Electric Stimulation; D004594:Electrophysiology; D006145:Guanethidine / Q000494:pharmacology; D066298:In Vitro Techniques; D009132:Muscles / Q000187:drug effects / Q000502:physiology; D009469:Neuromuscular Junction / Q000187:drug effects* / Q000502:physiology*; D009474:Neurons / Q000187:drug effects*; D010791:Phrenic Nerve / Q000187:drug effects / Q000502:physiology; D011343:Procaine / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*; D014403:Tubocurarine / Q000494:pharmacology
D000959:Antihypertensive Agents; D000963:Antimetabolites; D001949:Bretylium Compounds; D013565:Sympatholytics; D011343:Procaine; D014403:Tubocurarine; D006145:Guanethidine